143 results on '"Yang, Se Hwan"'
Search Results
2. Enabling immune checkpoint blockade efficacy in T-lymphopenia by restoring CD8 T cell dynamics with IL-7 cytokine therapy.
3. Recent progress on the seasonal tropical cyclone predictions over the western North Pacific from 2014 to 2020
4. Investigation of a potential protein biomarker signature that may predict clinical benefit of NT-I7 and pembrolizumab in patients with cold gastrointestinal tumors.
5. GX-I7(rhIL-7-hyFc, efineptakin alfa), a long-acting IL-7, safely and effectively increased peripheral CD8+ and CD4+ T cells and TILs in patients with solid tumors
6. EXTH-52. LONG-ACTING RECOMBINANT INTERLEUKIN-7, NT-I7, IMPROVES SURVIVAL FOLLOWING ONCOLYTIC ZIKA VIRUS TREATMENT IN THE SB28 IMMUNOSUPPRESSIVE AND TREATMENT-RESISTANT MURINE GLIOMA MODEL
7. 652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors
8. Influence of Global Warming on Western North Pacific Tropical Cyclone Intensities during 2015
9. (p40)2-Fc reduces immune-inflammatory response through the activation of T cells in collagen induced arthritis mice
10. Supplementary Figure from Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models
11. Supplementary Data from Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models
12. Data from Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses
13. Supplementary Figures 1-5 and 7-8 from Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses
14. Supplementary Figure 6 from Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses
15. 657 NT-I7, a long-acting IL-7, plus pembrolizumab favors CD8 T-cell infiltration in liver metastases of heavily pre-treated, immunologically cold, MSS-colorectal and pancreatic cancer
16. 624 A phase I/II study evaluating the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy
17. 679 NT-I7 for the treatment of locally recurrent squamous cell carcinoma of head and neck undergoing salvage surgery: a clinical trial in progress
18. Arterial Distension Monitoring Scheme Using FPGA-Based Inference Machine in Ultrasound Scanner Circuit System
19. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein
20. Biochemical characterization of a new recombinant TNF receptor-hyFc fusion protein expressed in CHO cells
21. Phase 1b/2 study of GX-I7 plus pembrolizumab in patients with refractory or recurrent (R/R) metastatic triple-negative breast cancer (mTNBC): The KEYNOTE-899 Study.
22. Recent progress on the seasonal tropical cyclone predictions over the western North Pacific from 2014 to 2020
23. Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models
24. Predictability of the East Asian winter monsoon indices by the coupled models of ENSEMBLES
25. Predictability of winter rainfall in South China as demonstrated by the coupled models of ENSEMBLES
26. CTIM-07. A PHASE I/II STUDY EVALUATING THE SAFETY AND EFFICACY OF A NOVEL LONG-ACTING INTERLEUKIN-7, NT-I7, FOR PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS AFTER CHEMORADIOTHERAPY
27. 396 NT-I7, a long-acting interleukin-7, promotes expansion of CD8 T cells and NK cells and immune activation in patients with newly diagnosed high-grade gliomas after chemoradiation
28. Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice
29. A phase I/II study to evaluate the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy: The interim result of the phase I data.
30. In vivo kinetics and biodistribution of HB-110, a novel HBV DNA vaccine, after administration in Mice
31. A long-acting erythropoietin fused with noncytolytic human Fc for the treatment of anemia
32. Effect of nonlytic Fc-fused IL-7 on influenza vaccine-induced IgG responses and protection: PS2-043
33. EXTH-14. A NOVEL LONG-ACTING INTERLEUKIN-7 AGONIST, NT-I7, INCREASES CYTOTOXIC CD8 CELLS AND ENHANCES SURVIVAL IN MOUSE GLIOMA MODELS
34. 450 Combination of rhIL-7-hyFc and anti-PD-L1xCD3ε bispecific antibody enhances antitumor response in mice
35. 565 A novel long-acting interleukin-7 agonist, NT-I7, increases cytotoxic CD8+ T cells and enhances survival in mouse glioma models
36. Preliminary safety and efficacy of GX-I7, a long-acting interleukin-7, in combination with pembrolizumab in patients with refractory or recurrent metastatic triple negative breast cancer (mTNBC): Dose escalation period of Phase Ib/II study (KEYNOTE-899).
37. hIL‐7‐hyFc, A Long‐Acting IL‐7, Increased Absolute Lymphocyte Count in Healthy Subjects
38. Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels
39. Efficient induction of T helper 1 CD4 + T-cell responses to hepatitis C virus core and E2 by a DNA prime–adenovirus boost
40. Abstract 4991: Hyleukin-7, the Fc-fused interleukin-7, generates anti-tumor activity by modulating both adaptive and innate immune cells in the tumor microenvironment
41. Abstract CT045: Hyleukin-7, a long-acting interleukin-7, increased absolute lymphocyte counts after subcutaneous and intramuscular administration in healthy subjects
42. Effect of a novel long-acting interleukin-7 agonist, NT-I7, on survival in mouse models of glioma.
43. A Single Administration of Fc-Fused Recombinant Human IL-7 Induces Expansions of T Lymphocytes in Healthy Adult Volunteers
44. Hepatitis C Virus Core Inhibits the Fas-mediated p38 Mitogen Activated Kinase Signaling Pathway in Hepatocytes
45. Hepatitis C Virus Core Protein Inhibits Interleukin 12 and Nitric Oxide Production from Activated Macrophages
46. HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation
47. Internal Cleavage of Hepatitis C Virus NS3 Protein Is Dependent on the Activity of NS34A Protease
48. Abstract 1731: Preclinical evaluation of the anti-tumor activity of Fc-fused interleukin-7 in both monotherapy and combination therapy
49. IL-12p40 Homodimer Ameliorates Experimental Autoimmune Arthritis
50. Crucial Roles of Interleukin-7 in the Development of T Follicular Helper Cells and in the Induction of Humoral Immunity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.